For: | Ding L, Xu WJ, Tao XY, Zhang L, Cai ZG. Clinicopathological features of superficial CD34-positive fibroblastic tumor. World J Clin Cases 2021; 9(12): 2739-2750 [PMID: 33969057 DOI: 10.12998/wjcc.v9.i12.2739] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i12/2739.htm |
Number | Citing Articles |
1 |
Haneen T. Salah, Julieta A. D'Ardis, Donghwa Baek, Juanita Duran, Mary R. Schwartz, Alberto G. Ayala, Jae Y. Ro. Case of recurrent superficial CD34‐positive fibroblastic tumor. Journal of Cutaneous Pathology 2023; 50(6): 477 doi: 10.1111/cup.14329
|
2 |
Haneen T. Salah, Julieta A. D'ardis, Donghwa Baek, Mary R. Schwartz, Alberto G. Ayala, Jae Y. Ro. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features. Annals of Diagnostic Pathology 2022; 58: 151937 doi: 10.1016/j.anndiagpath.2022.151937
|
3 |
Bruce M. Wenig, Juan C. Hernandez-Prera. Atlas of Head and Neck Pathology. 2023; : 673 doi: 10.1016/B978-0-323-71257-6.00013-7
|
4 |
Raul Perret, Isabelle Hostein. Superficial CD34-Positive Fibroblastic Tumor. Surgical Pathology Clinics 2024; 17(1): 1 doi: 10.1016/j.path.2023.06.001
|
5 |
Olisaemeka Chukwudebe, Ryanne A. Brown. Immunohistochemical and molecular updates in cutaneous soft tissue neoplasms. Seminars in Diagnostic Pathology 2022; 39(4): 257 doi: 10.1053/j.semdp.2022.02.004
|